Search research articles
Contact Us
Filters
Showing results (11-20 of 30) with videos related to
Page
of 3
Sort By:
Plos One
|
December 29, 2015
The Cell Death Inhibitor ARC Is Induced in a Tissue-Specific Manner by Deletion of the Tumor Suppressor Gene Men1, but Not Required for Tumor Development and Growth
Wendy M McKimpson, Ziqiang Yuan, Min Zheng, et al.
Molecular and Cellular Endocrinology
|
March 28, 2008
Activity of three selective estrogen receptor modulators on hormone-dependent responses in the mouse uterus and mammary gland
Judy S Crabtree, Bryan J Peano, Xiaochun Zhang, et al.
Cancer Prevention Research (Philadelphia, Pa.)
|
February 25, 2010
Loss of inhibitory insulin receptor substrate-1 phosphorylation is an early event in mammalian target of rapamycin-dependent endometrial hyperplasia and carcinoma
Adrienne S McCampbell, Heather A Harris, Judy S Crabtree, et al.
Experimental Biology and Medicine (Maywood, N.J.)
|
February 8, 2022
ISGylation is increased in the peripheral blood mononuclear cells derived from symptomatic COVID-19 patients
Joshua Schwartzenburg, Ryan Reed, Hari Koul, et al.
Methods in Molecular Biology (Clifton, N.J.)
|
December 3, 2021
ER+ Breast Cancer Mammosphere Formation and Analysis
Ciera S Singleton, Leo Li-Ying Chan, Kelsey J McCulley, et al.
Journal of Clinical and Translational Science
|
January 12, 2026
Long COVID incidence across SARS-CoV-2 lineages and identification of conserved spike targets for multivalent vaccines
Grace Jaeyoon Kim, Md Ashad Alam, Judy S Crabtree, et al.
Mammalian Genome : Official Journal of the International Mammalian Genome Society
|
January 28, 2005
Homozygous loss of menin is well tolerated in liver, a tissue not affected in MEN1
Peter C Scacheri, Judy S Crabtree, Alyssa L Kennedy, et al.
Oncotarget
|
September 3, 2016
Acquisition of an oncogenic fusion protein serves as an initial driving mutation by inducing aneuploidy and overriding proliferative defects
Jacob M Loupe, Patrick J Miller, Benjamin P Bonner, et al.
The Oncologist
|
August 19, 2022
DLL3 as an Emerging Target for the Treatment of Neuroendocrine Neoplasms
James Yao, Emily Bergsland, Rahul Aggarwal, et al.
Endocrinology
|
March 18, 2010
A mouse model of androgenetic alopecia
Judy S Crabtree, Edward J Kilbourne, Bryan J Peano, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 30) with videos related to
Sort By:
Page
of 3
Plos One
|
December 29, 2015
The Cell Death Inhibitor ARC Is Induced in a Tissue-Specific Manner by Deletion of the Tumor Suppressor Gene Men1, but Not Required for Tumor Development and Growth
Wendy M McKimpson, Ziqiang Yuan, Min Zheng, et al.
Molecular and Cellular Endocrinology
|
March 28, 2008
Activity of three selective estrogen receptor modulators on hormone-dependent responses in the mouse uterus and mammary gland
Judy S Crabtree, Bryan J Peano, Xiaochun Zhang, et al.
Cancer Prevention Research (Philadelphia, Pa.)
|
February 25, 2010
Loss of inhibitory insulin receptor substrate-1 phosphorylation is an early event in mammalian target of rapamycin-dependent endometrial hyperplasia and carcinoma
Adrienne S McCampbell, Heather A Harris, Judy S Crabtree, et al.
Experimental Biology and Medicine (Maywood, N.J.)
|
February 8, 2022
ISGylation is increased in the peripheral blood mononuclear cells derived from symptomatic COVID-19 patients
Joshua Schwartzenburg, Ryan Reed, Hari Koul, et al.
Methods in Molecular Biology (Clifton, N.J.)
|
December 3, 2021
ER+ Breast Cancer Mammosphere Formation and Analysis
Ciera S Singleton, Leo Li-Ying Chan, Kelsey J McCulley, et al.
Journal of Clinical and Translational Science
|
January 12, 2026
Long COVID incidence across SARS-CoV-2 lineages and identification of conserved spike targets for multivalent vaccines
Grace Jaeyoon Kim, Md Ashad Alam, Judy S Crabtree, et al.
Mammalian Genome : Official Journal of the International Mammalian Genome Society
|
January 28, 2005
Homozygous loss of menin is well tolerated in liver, a tissue not affected in MEN1
Peter C Scacheri, Judy S Crabtree, Alyssa L Kennedy, et al.
Oncotarget
|
September 3, 2016
Acquisition of an oncogenic fusion protein serves as an initial driving mutation by inducing aneuploidy and overriding proliferative defects
Jacob M Loupe, Patrick J Miller, Benjamin P Bonner, et al.
The Oncologist
|
August 19, 2022
DLL3 as an Emerging Target for the Treatment of Neuroendocrine Neoplasms
James Yao, Emily Bergsland, Rahul Aggarwal, et al.
Endocrinology
|
March 18, 2010
A mouse model of androgenetic alopecia
Judy S Crabtree, Edward J Kilbourne, Bryan J Peano, et al.
Page
of 3